µÚÒ»·¶ÎÄÍø - רҵÎÄÕ·¶ÀýÎĵµ×ÊÁÏ·ÖÏíÆ½Ì¨

Á÷Ðв¡Ñ§

À´Ô´£ºÓû§·ÖÏí ʱ¼ä£º2025/5/24 5:58:19 ±¾ÎÄÓÉloading ·ÖÏí ÏÂÔØÕâÆªÎĵµÊÖ»ú°æ
˵Ã÷£ºÎÄÕÂÄÚÈݽö¹©Ô¤ÀÀ£¬²¿·ÖÄÚÈÝ¿ÉÄܲ»È«£¬ÐèÒªÍêÕûÎĵµ»òÕßÐèÒª¸´ÖÆÄÚÈÝ£¬ÇëÏÂÔØwordºóʹÓá£ÏÂÔØwordÓÐÎÊÌâÇëÌí¼Ó΢ÐźÅ:xxxxxxx»òQQ£ºxxxxxx ´¦Àí£¨¾¡¿ÉÄܸøÄúÌṩÍêÕûÎĵµ£©£¬¸ÐлÄúµÄÖ§³ÖÓëÁ½⡣

ÍöËùËðʧµÄÈ«²¿½¡¿µÊÙÃüÄê

17.±¬·¢£¨outbreak£©ÔÚÒ»¸ö¾Ö²¿µØÇøºÍ¼¯Ì嵥λÖУ¬¶Ìʱ¼äÄÚºöÈ»ÓкܶàÏàͬµÄ²¡È˳öÏÖ

18.Á÷ÐУ¨epidemic£©Ä³²¡ÔÚijµØÇøÏÔÖø³¬¹ý¸Ã²¡ÀúÄêµÄ·¢²¡ÂÊˮƽʱ 1.ÃèÊöÐÔÑо¿£¨discrible study£©Í¨¹ýÃèÊö¼²²¡ »ò½¡¿µ×´¿öÖ®¼äµÄ¹ØÏµ£¬Ìṩ²¡ÒòÏßË÷£¬ËüÊÇÁ÷Ðв¡Ñ§µ÷²éµÄµÚÒ»²½£¬Ò²ÊÇ·ÖÎöÁ÷Ðв¡Ñ§µÄ»ù´¡

2.Ëæ»ú³éÑù·½·¨ µ¥´¿Ëæ»ú³éÑù£ºÏµÍ³³éÑù£¬·Ö²ã³éÑù£¬ÕûȺ³éÑù£¬¶à¼¶³éÑù£¨1£©µ¥´¿Ëæ»ú³éÑù£¨simple random samping)Ò²³Æ¼òµ¥Ëæ»ú³éÑù£¬×î¼òµ¥×î»ù±¾µÄ³éÑù·½·¨¢Ú´Ó×ÜÌåN¸ö¶ÔÏóÖÐÓ¦ÓóéÇ©ºÍÆäËûËæ»ú·½·¨³éÈ¡n¸ö¢Û×ÜÌåÖÐÿ¸ö¶ÔÏ󱻳鵽µÄ¸ÅÂÊÏàµÈ£¨2£©ÏµÍ³³éÑù£¨systemic samping£©Óֳƻúе³éÑù,°´ÕÕÒ»¶¨Ë³Ðò£¬»úеÿ¸öÈô¸Éµ¥Î»³éȡһ¸öµ¥Î».·½·¨¢Ù½«×ÜÌå¸÷¸ö¸öÌ嵥λ°´Ä³ÖÖ±êÖ¾ÅÅÁÐÁ¬Ðø±àºÅ¢Ú¸ù¾Ý×ÜÌåÊýNºÍÈ·¶¨µÄÑù±¾Êýn£¬¼ÆËã³éÑù¾àÀ루N/n£©¢ÛµÚÒ»¶Î¾àÀëÄÚËæ»ú³éȡһ¸öºÅÂë×÷ΪµÚÒ»¸öµ÷²éÑù±¾µ¥Î»¢Ü½«µÚÒ»¸öÑù±¾µ¥Î»µÄºÅÂëÉϳéÑù¾àÀëµÃµ½µÚ¶þ¸öÑù±¾µ¥Î»ÒÀ´ËÀàÍÆÖ±ÖÁÂú×ãÑù±¾Á¿£¨4£©·Ö²ã³éÑù¢Ù½«×ÜÌ嵥λ°´Ä³ÖÖÌØÕ÷·ÖΪÈô¸É´Î¼¶×ÜÌå¢Ú´Óÿһ²ãµ¥¶ÀËæ»ú³éÑù£¨5£©ÕûȺ³éÑù¢Ù½«×ÜÌå·ÖΪÈô¸ÉȺ×é¢Ú³é³ö²¿·ÖȺ×é¢Úµ¥´¿ÕûȺ³éÑù£ºµ÷²é±»³éµ½µÄȺ×éÖеÄÈ«²¿¸öÌå¢Û¶þ½×¶Î³éÑù£ºµ÷²é²¿·Ö¸öÌ壨6£©¶à¼¶³éÑù×ÛºÏÉÏÊö³éÑù·½·¨Ó¦ÓÃÓÚ´óÐÍÁ÷Ðв¡Ñ§µ÷²é¡£·½·¨£º¢Ù´Ó×ÜÌåÖгéÈ¡·¶Î§½Ï´óµÄµ¥Ôª£¨Ò»¼¶³éÑù£©¢Ú´ÓÒ»¼¶µ¥ÔªÖгéÈ¡·¶Î§½ÏСµÄµ¥Ôª£¨¶þ¼¶³éÑù£©

1.¶ÓÁÐÑо¿(cohort study)½«Ò»¸ö·¶Î§Ã÷È·µÄÈËȺ°´ÕÕÊÇ·ñ±©Â¶ÓÚij¿ÉÒÉÒòËØ¼°Æä±©Â¶³Ì¶È·ÖΪ²»Í¬ÑÇ×é£¬Ëæ·Ã¹Û²ìÒ»¶¨µÄʱ¼ä£¬×·×ÙÆä¸÷×ԵĽá¾Ö£¬±È½Ï²»Í¬ÑÇ×éÖ®¼ä½á¾ÖµÄ²îÒ죨һ°ãÖ¸·¢²¡ÂʺÍËÀÍöÂÊ£©´Ó¶øÅжϱ©Â¶ÒòËØÓë½á¾ÖÖ®¼äÓÐÎÞÒò¹û¹ØÁªÒÔ¼°¹ØÁª´óСµÄÒ»ÖÖ¹Û²ìÐÔÑо¿·½·¨

3.¶ÓÁÐÑо¿µÄÓŵãºÍȱµã£¨1£©Óŵã1.¿ÉÒÔÖ±½Ó»ñµÃ±©Â¶×éÓë·Ç±©Â¶×éµÄ·¢²¡ÂʺÍËÀÍöÂÊ£¬Òò¶ø¿ÉÒÔÖ±½Ó¹À¼ÆÏà¶ÔΣÏÕ¶È£¨RR£©µÈ·´Ó³±©Â¶ÓÚ¼²²¡¹ØÁª³Ì¶ÈµÄÖ¸±ê£¬¿ÉÒÔ³ä·Ö¶øÖ±½ÓµÄ·ÖÎö±©Â¶µÄ²¡Òò×÷ÓÃ2.ÓÉÓÚÔ­Òò·¢ÉúÔÚǰ£¬½á¾Ö·¢ÉúÔÚºó£¬Òò¹ûʱ¼ä˳ÐòÃ÷È·£¬¼Ó֮ƫéóÓÖÉÙ£¬ÓÖ¿ÉÖ±½Ó¼ÆËã¸÷Ïî²âÁ¿¼²²¡Î£ÏÕ¹ØÁªµÄÖ¸±ê£¬ËùÒÔ¼ìÑ鲡Òò¼Ù˵µÄÄÜÁ¦½ÏÇ¿£¬¿ÉÕýʽ²¡ÒòÁªÏµ¡£4.Ñù±¾Á¿´ó£¬½á¹û±È½ÏÎȶ¨¡£ÓÐʱ»¹¿ÉÄÜ»ñµÃ¶àÖÖÔ¤¼ÆÒÔÍâµÄ¼²²¡½á¾Ö×ÊÁÏ£¬·ÖÎöÒ»ÖÖÔ­ÒòÓë¶àÖÖ¼²²¡µÄ¹ØÏµ£¬Ò²¿ÉÒÔ·ÖÎö¶àÖÖÔ­ÒòÓëÒ»ÖÖ»ò¶àÖÖ¼²²¡Ö®¼äµÄ¹ØÏµ¡£5.ÓÉÓÚÑо¿¶ÔÏó±©Â¶×ÊÁϵÄÊÕ¼¯ÔÚ½á¾Ö·¢Éú֮ǰ£¬²¢ÇÒ¶¼ÊÇÓÉÑо¿ÕßÇ××Ô¹Û²ìµÃµ½ËùÒÔ×ÊÁÏÍêÕû¿É¿¿£¬»ØÒ䯫ÒÐÏà¶Ô½ÏС¡££¨2£©È±µã1.²»ÊÊÓÚ·¢²¡Âʺܵ͵ļ²²¡µÄ²¡ÒòÑо¿£¬ÒòΪÐèÒª½Ï´óµÄÈËȺ£¬Ñо¿µÄʵʩÓÐÒ»¶¨À§ÄÑ¡£2.ÓÉÓÚ³¤ÆÚµÄÑо¿ÓëËæ·Ã£¬ÒòΪËÀÍö¡¢Í˳öÔì³ÉµÄʧ·ÃÄÑÒÔ±ÜÃ⣬ÈÝÒײúÉúʧ·ÃÆ«ÒС£3.Ñо¿·Ñʱ¼ä¡¢·ÑÈËÁ¦¡¢»¨·Ñ¸ß£¬×éÖ¯ÓëºóÇÚ¹¤×÷Ï൱¼è¾Þ¡£4.Ëæ×Åʱ¼äÍÆÒÆ£¬Î´ÖªµÄ±äÁ¿ÒýÈëÈËȺ£¬ºÍÈËȺÖÐÒÑÖª±äÁ¿µÄ±ä»¯£¬¿ÉÄܵ¼Ö½á¾ÖÊÜÓ°Ï죬ʹ·ÖÎö¸´ÔÓ»¯¡£5.Ñо¿µÄÉè¼ÆÒªÇó¸ß£¬ÊµÊ©ÄѶȴó¡£

16.¶ÓÁÐÑо¿Öг£¼ûµÄÆ«ÒÐ1.Ô­ÔòÆ«ÒÐ2.ʧ·ÃÆ«ÒÐ3.ÐÅϢƫÒÐ4¡£»ìÔÓ

Æ«ÒÐ

1.²¡Àí¶ÔÕÕ£¨case-control study£©Ñ¡Ò»ÖÖ»¼ÓÐÎÒÃÇÏëÑо¿µÄ¼²²¡µÄÈË×÷Ϊ²¡Àý×飬²¢Ñ¡Ò»×éδ»¼¸Ã²¡µÄÈË×÷Ϊ¶ÔÕÕ×飬·Ö±ðµ÷²éÁ½×éÈËȺ¼ÈÍù±©Â¶ÓÚij¸öÒòËØµÄ±©Â¶Çé¿ö¼°±©Â¶³Ì¶È£¬ÒÔÅжϱ©Â¶ÓÚij¸öÒòËØÓë¸Ã²¡ÓÐÎÞ¹ØÁª¼°¹ØÁª³Ì¶È´óСµÄÒ»ÖÖ¹Û²ìÐÔÑо¿·½·¨

2.Æ¥Å䣨matching£©ÓÖ³Æ×÷Åä±È£¬ÊÇÖ¸ËùÑ¡ÔñµÄ¶ÔÕÕÔÚijЩÒòËØºÍÌØÕ÷ÉÏÓ벡Àý±£³ÖÒ»Ö£¬ÆäÄ¿µÄÊÇÇå³ýÕâЩÒòËØ¶ÔÑо¿½á¹ûµÄ¸ÉÈÅ£¬Ìá¸ßÑо¿µÄЧÂÊ¡£ÕâЩÒòËØºÍÌØÕ÷ÓÖ³ÆÎªÆ¥Åä±äÁ¿ºÍÆ¥ÅäÒòËØ¡£ 1.Ëæ»ú¶ÔÕÕÊÔÑ飨randomized clinical trial£¬RCT£©Ëæ»ú¶ÔÕÕÊÔÑéÊǽ«Ñо¿ÈËÈºËæ»ú·ÖΪʵϰ×éºÍ¶ÔÕÕ×飬½«Ñо¿ÕßËù¿ØÖƸøÓèʵÑéÈËȺºó£¬Ëæ·Ã¹Û²ì²¢±È½ÏÁ½×éÈËȺµÄ½á¾Ö£¬ÒÔÅжϴëÊ©µÄЧ¹û¡£ 3.ä·¨£¨blinding»òmasking£©ÊÇÖ¸ÊÇÑо¿¶ÔÏóºÍÑо¿Õß²»ÖªµÀÑо¿µÄ·Ö×éÇé¿ö£¬Ò²¾ÍÊDz»ÖªµÀijÑо¿¶ÔÏóµ½µ×½ÓÊÜʲôÑùµÄ¸ÉÔ¤ 4.µ¥Ã¤·¨£¨single blind£©ÊÇÖ¸Ñо¿¶ÔÏó²»ÖªµÀ×Ô¼ºµÄ·Ö×éºÏºÍËù½ÓÊÜ´¦ÀíÇé¿ö£¬µ±¹Û²ìÕߺÍ×ÊÁÏÊÕ¼¯·ÖÎöÕßÖªµÀ

5.˫ä·¨£¨double blind trial£©Ñо¿¶ÔÏóºÍ¹Û²ìÕß¶¼²»ÖªµÀ·Ö×éÇé¿ö£¬Ò²²»ÖªµÀÑо¿¶ÔÏó½ÓÊÜ´¦Àí´ëÊ©

6.Èýä·¨£¨triple blind trial£©ÊÇÑо¿¶ÔÏó¹Û²ìÕߺÍ×ÊÁÏÕûÀí·ÖÎöÕß¶¼²»ÖªµÀÑо¿¶ÔÏóµÄ·Ö×éºÍ´¦ÀíÇé¿ö£¬Ö»ÓÐÑо¿ÕߺÍÖÆÔìÉÌÖªµÀ£¬Ö±µ½ÊµÑé½áÊøºó²Å¹«²¼·Ö×éºÍ´¦ÀíÇé¿ö

1.ÕæÊµÐÔ£¨validity:ÓÖ³Æ×¼È·¶ÈºÕ¶ûЧ¶È£¬ÊÇÖ¸Õï¶ÏÊÔÑéËù»ñµÃµÄ²âÁ¿ÖµÓëʵ¼ÊÇé¿öµÃ·ûºÏ¶È¡£

2.ÁéÃô¶È£¨sensititity£©Êµ¼ÊÓв¡µÄÈËÕýÈ·ÅÐΪ»¼ÕߵĸÅÂÊ£¬ÓÖ³ÆÕæÑøÐÔÂÊ¡£

3.ÌØÒì¶È£¨specificity£©Êµ¼ÊÎÞ²¡µÄÈËÅÐΪ»¼ÕߵĸÅÂÊ£¬ÓÖ³ÆÕæÒõÐÔÂÊ¡£ 4.ÑôÐÔÔ¤²âÖµ£¨positive predictive value,+pv£©Ö¸Õï¶ÏÊÔÑéÑôÐÔ½á¹ûÖÐÕæÕý»¼²¡µÄ±ÈÀý¡£

5.ÒõÐÔÔ¤²âÖµ£¨negative predictive value,_pv£©Ö¸Õï¶ÏÊÔÑéÒõÐÔ½á¹ûÖÐÕæÕýδ»¼²¡µÄ±ÈÀý¡£

6.¿É¿¿ÐÔ£¨reliability£©Ö¸Õï¶ÏÊÔÑéÔÚÏàͬÌõ¼þϽøÐÐÖØ¸´²Ù×÷»ñµÃÏàͬ½á¹ûµÄÎȶ¨³Ì¶È£¬Óֳƾ«È·¶È¡£

7.Èý½ÇÄ£ÐÍ£¨triangle modle£©Òà³ÆÁ÷Ðв¡Ñ§Èý½Ç£¨triangle of eidemiology£©£¬¸ÃÄ£ÐÍÈÏΪ¼²²¡µÄ·¢ÉúÊÇËÞÖ÷¡¢»·¾³¡¢²¡Òò£¨¶¯Òò£©ÈýÒªËØ¹²Í¬×÷ÓõĽá¹û¡£

8¡£Âß¼­Ë¼Î¬µÄ·½·¨£º1¡¢¼ÙÉèÑÝÒï·¨£¨hypothetic deductive method£© 2¡¢mill×¼Ôò£¨mill cannon£©3¡¢Çóͬ·¨£¨method of agreement£©4¡¢ÇóÒì·¨£¨method of difference£©5¡¢¹²±ä·¨£¨method of concomitant varriation£©6¡¢ÀàÍÆ·¨£¨method of analogy£©7¡¢Åųý·¨£¨method of exclusion£© 9.³£ÓõÄÒò¹ûÍÆ¶Ï±ê×¼£º1¡¢¹ØÁªµÄÇ¿¶È2¡¢¹ØÁªµÄʱ¼ä˳Ðò3¡¢¹ØÁªµÄÌØÒìÐÔ4¡¢¹ØÁªµÄ¿ÉÖØ¸´ÐÔ5¡¢¼ÁÁ¿·´Ó¦¹ØÏµ6¡¢ÒòËØÓë¼²²¡·Ö ²¼Ò»ÖÂÐÔ7¡¢ÊµÑéÖ¤¾Ý9¡¢ÏàËÆÐÔ

1.´«È¾Ô´£¨source of infection,reservoir of infection£©ÊÇÖ¸ÌåÄÚÓв¡Ô­ÌåÉú³¤¡¢·±Ö³£¬²¢ÄÜÅųö²¡Ô­ÌåµÄÈ˺Ͷ¯Îï¡£°üÀ¨²¡ÈË¡¢²¡Ô­Ð¯´øÕߺÍÊܸÐȾ¶¯Îï¡£

ËÑË÷¸ü¶à¹ØÓÚ£º Á÷Ðв¡Ñ§ µÄÎĵµ
Á÷Ðв¡Ñ§.doc ½«±¾ÎĵÄWordÎĵµÏÂÔØµ½µçÄÔ£¬·½±ã¸´ÖÆ¡¢±à¼­¡¢ÊղغʹòÓ¡
±¾ÎÄÁ´½Ó£ºhttps://www.diyifanwen.net/c3sagr33m9r3jk4h7sniv_3.html£¨×ªÔØÇë×¢Ã÷ÎÄÕÂÀ´Ô´£©
ÈÈÃÅÍÆ¼ö
Copyright © 2012-2023 µÚÒ»·¶ÎÄÍø °æÈ¨ËùÓÐ ÃâÔðÉùÃ÷ | ÁªÏµÎÒÃÇ
ÉùÃ÷ :±¾ÍøÕ¾×ðÖØ²¢±£»¤ÖªÊ¶²úȨ£¬¸ù¾Ý¡¶ÐÅÏ¢ÍøÂç´«²¥È¨±£»¤ÌõÀý¡·£¬Èç¹ûÎÒÃÇ×ªÔØµÄ×÷Æ·ÇÖ·¸ÁËÄúµÄȨÀû,ÇëÔÚÒ»¸öÔÂÄÚ֪ͨÎÒÃÇ£¬ÎÒÃǻἰʱɾ³ý¡£
¿Í·þQQ£ºxxxxxx ÓÊÏ䣺xxxxxx@qq.com
ÓåICP±¸2023013149ºÅ
Top